Increasing evidence suggests that ion channels not only regulate electric signaling in excitable cells but also play important roles in the development of brain tumor. However, the roles of ion channels in glioma remain controversial. In the present study, we systematically analyzed the expression patterns of ion channel genes in a cohort of Chinese patients with glioma using RNAseq expression profiling. First, a molecular signature comprising three ion channel genes (KCNN4, KCNB1 and KCNJ10) was identified using Univariate Cox regression and two-tailed student's t test conducted in overall survival (OS) and gene expression. We assigned a risk score based on three ion channel genes to each primary Glioblastoma multiforme (pGBM) patient. We demonstrated that pGBM patients who had a high risk of unfavorable outcome were sensitive to chemotherapy. Next, we screened the three ion genes-based signature in different molecular glioma subtypes. The signature showed a Mesenchymal subtype and wild-type IDH1 preference. Gene ontology (GO) analysis for the functional annotation of the signature showed that patients with high-risk scores tended to exhibit the increased expression of proteins associated with apoptosis, immune response, cell adhesion and motion and vasculature development. Gene Set Enrichment Analysis (GSEA) results showed that pathways associated with negative regulation of programmed cell death, cell proliferation and locomotory behavior were highly expressed in the high-risk group. These results suggest that ion channel gene expression could improve the subtype classification in gliomas at the molecular level. The findings in the present study have been validated in two independent cohorts.
基金:
Guangdong Provincial Clinical Medical Centre for Neurosurgery [2013B020400005]; Beijing science and technology plan [Z131100006113018]; National Natural Science Foundation of ChinaNational Natural Science Foundation of China [81371397, 91229121, 81272804, 81071011]; National High Technology Research and Development ProgramNational High Technology Research and Development Program of China [2012AA02A508]; International Science and Technology Cooperation Program [2012DFA30470]
第一作者机构:[1]Southern Med Univ, Zhujiang Hosp, Dept Neurosurg, Guangzhou, Guangdong, Peoples R China;[2]Southern Med Univ, Key Lab Brain Funct Repair & Regenerat, Natl Key Clin Specialty,Engn Technol Res Ctr, Dept Neurosurg,Zhujiang Hosp,Minist China Guangdo, Guangzhou, Guangdong, Peoples R China;[4]Capital Med Univ, Beijing Neurosurg Inst, Beijing, Peoples R China;[5]CGCG, Beijing, Peoples R China;
通讯作者:
通讯机构:[1]Southern Med Univ, Zhujiang Hosp, Dept Neurosurg, Guangzhou, Guangdong, Peoples R China;[2]Southern Med Univ, Key Lab Brain Funct Repair & Regenerat, Natl Key Clin Specialty,Engn Technol Res Ctr, Dept Neurosurg,Zhujiang Hosp,Minist China Guangdo, Guangzhou, Guangdong, Peoples R China;[5]CGCG, Beijing, Peoples R China;[6]Capital Med Univ, Beijing Tiantan Hosp, Dept Radiat Therapy, Beijing, Peoples R China;
推荐引用方式(GB/T 7714):
Wang Hao-Yuan,Li Ji-Ye,Liu Xiu,et al.A three ion channel genes-based signature predicts prognosis of primary glioblastoma patients and reveals a chemotherapy sensitive subtype[J].ONCOTARGET.2016,7(46):74895-74903.doi:10.18632/oncotarget.12462.
APA:
Wang, Hao-Yuan,Li, Ji-Ye,Liu, Xiu,Yan, Xiao-Yan,Wang, Wen...&Zhang, Shi-Zhong.(2016).A three ion channel genes-based signature predicts prognosis of primary glioblastoma patients and reveals a chemotherapy sensitive subtype.ONCOTARGET,7,(46)
MLA:
Wang, Hao-Yuan,et al."A three ion channel genes-based signature predicts prognosis of primary glioblastoma patients and reveals a chemotherapy sensitive subtype".ONCOTARGET 7..46(2016):74895-74903